GetTopicDetailResponse(id=89f645e49a9, topicName=安全評估, introduction=安全評估, content=null, image=null, comments=1, allHits=962, url=https://h5.medsci.cn/topic?id=45749, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=14105, tagList=[TagDto(tagId=14105, tagName=安全評估)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2054577, encodeId=688220545e7e3, content=<a href='/topic/show?id=89f645e49a9' target=_blank style='color:#2F92EE;'>#安全評估#</a>, objectTitle=Diabetes Care：GLP-1受體激動劑dulaglutide治療的胰腺安全評估分析！, objectType=article, longId=91502, objectId=711891502a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=711891502a5, replyNumber=0, likeNumber=90, createdTime=2018-01-13, rootId=0, userName=1249894fm73暫無昵稱, userId=9de22500104, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=711891502a5, moduleTitle=Diabetes Care：GLP-1受體激動劑dulaglutide治療的胰腺安全評估分析！, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=711891502a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
